STOCK TITAN

Curtiss-Wright (CW) director Moraco receives $160,000 restricted stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Curtiss-Wright director Anthony J. Moraco received an annual equity award of 256 shares of common stock on February 4, 2026. The shares were granted under the company’s 2024 Omnibus Incentive Plan as restricted stock for his service on the board.

The award value was $160,000, calculated using the closing share price of $624.93 on the grant date and rounded down to the nearest whole share. Restrictions lapse after one year or earlier if his board service ends due to death, disability, or failure to be reelected. Following this grant, Moraco directly holds 5,446 shares of Curtiss-Wright common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moraco Anthony J

(Last) (First) (Middle)
C/O CURTISS-WRIGHT CORPORATION
130 HARBOUR PLACE DRIVE

(Street)
DAVIDSON NC 28036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/04/2026 A(1) 256(2) A $624.93(3) 5,446 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which non-employee directors receive an annual grant of restricted stock for service on the board. The restrictions on these shares lapse upon the shorter of (a) one year from the date of grant or (b) until such time as the service of the recipient as a non-employee Director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.
2. The number of shares is arrived by dividing the closing price of the Issuer's securities on February 4, 2026 into $160,000, the amount of the stock award granted to the Issuer's non-employee directors. The number of shares is rounded down to the nearest whole share.
3. Price is based on the close price for the Registrant's common stock on February 4, 2026, the date the reporting person earned the annual award.
Remarks:
George P. McDonald By Power of Attorney for Anthony J. Moraco 02/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Curtiss-Wright (CW) director Anthony J. Moraco report on this Form 4?

Anthony J. Moraco reported receiving 256 shares of Curtiss-Wright common stock as a board compensation grant. These restricted shares were awarded under the 2024 Omnibus Incentive Plan and are tied to his service as a non-employee director on the company’s board.

How was the number of shares in Moraco’s Curtiss-Wright (CW) stock award determined?

The award was set at $160,000 and converted into 256 shares using Curtiss-Wright’s February 4, 2026 closing price of $624.93. The calculation divided $160,000 by that closing price and then rounded down to the nearest whole share, as described in the footnotes.

When do the restrictions on Anthony J. Moraco’s Curtiss-Wright (CW) restricted stock lapse?

Restrictions lapse on the earlier of one year from the February 4, 2026 grant date or when Moraco’s service as a non-employee director ends due to death, disability, or failure to be reelected. These conditions define when the restricted shares become fully vested.

How many Curtiss-Wright (CW) shares does Anthony J. Moraco own after this transaction?

After the reported grant, Anthony J. Moraco beneficially owns 5,446 shares of Curtiss-Wright common stock directly. This total includes the newly awarded 256 restricted shares reported in the Form 4 and reflects his holdings immediately following the transaction date.

Is Moraco’s Curtiss-Wright (CW) Form 4 transaction a purchase or a grant?

The Form 4 reflects an award of shares, not an open-market purchase. The 256 shares were issued as restricted stock under Curtiss-Wright’s 2024 Omnibus Incentive Plan as part of Moraco’s annual compensation for serving as a non-employee director on the board.

What role does Curtiss-Wright’s 2024 Omnibus Incentive Plan play in Moraco’s Form 4 filing?

The 2024 Omnibus Incentive Plan is the framework authorizing the restricted stock grant reported. Under this plan, non-employee directors receive annual stock awards for board service, with vesting and lapse of restrictions governed by plan terms tied to tenure and specific separation events.
Curtiss Wright Corp

NYSE:CW

CW Rankings

CW Latest News

CW Latest SEC Filings

CW Stock Data

22.81B
36.68M
0.55%
86.51%
1.14%
Aerospace & Defense
Misc Industrial & Commercial Machinery & Equipment
Link
United States
DAVIDSON